Meyahealth
HomeGeneticsGenePHKA1 gene
Back to Gene
PHKA1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

PHKA1 gene

The PHKA1 gene encodes a subunit of the phosphorylase b kinase enzyme, which is vital for energy production in muscle cells.

Normal Function

The PHKA1 gene provides instructions for making the alpha subunit of the phosphorylase b kinase enzyme. This enzyme is composed of 16 subunits and is found in various tissues, with high concentrations in the liver and muscles. The alpha-1 subunit produced by PHKA1 is specific to the version of the enzyme found in muscle cells.

Phosphorylase b kinase is essential for cellular energy production. It activates glycogen phosphorylase b, which breaks down glycogen—a stored form of glucose—into glucose when the body requires energy, such as during exercise.

Health Conditions Related to Genetic Changes

Glycogen storage disease type IX

Mutations in the PHKA1 gene can cause a rare form of glycogen storage disease type IX (GSD IX), specifically GSD IXd or X-linked muscle glycogenosis. This condition affects the muscles and can lead to:

  • Muscle weakness
  • Muscle pain
  • Cramping, particularly during exercise

These mutations reduce the activity of phosphorylase b kinase in muscle cells, impairing the breakdown of glycogen. As a result, glycogen accumulates in the cells, and glucose is not readily available for energy, leading to the symptoms associated with the disorder.

Genomic Location

The PHKA1 gene is located on the X chromosome.

Frequently Asked Questions

Confirmation typically involves a combination of genetic testing and biochemical assays. A DNA test (usually next‑generation sequencing or a targeted PHKA1 panel) identifies pathogenic variants. In addition, a muscle biopsy may be performed to measure phosphorylase b kinase activity; reduced activity supports the diagnosis. Blood tests for glycogen content or lactate levels during exercise can also provide supportive evidence.
Staying well hydrated, warming up properly before activity, and avoiding sudden, intense exertion can reduce cramping. Consuming a small snack rich in simple carbohydrates (like a banana or sports drink) 30–60 minutes before exercise can provide immediate glucose. Some patients find that gradual, progressive training improves tolerance, while others may need to limit high‑intensity workouts. Regular follow‑up with a dietitian and physiotherapist can tailor a plan that balances activity with safety.
Management focuses on preventing muscle breakdown and improving exercise tolerance. A high‑carbohydrate diet, especially before exercise, can help supply glucose directly to muscles. Some patients benefit from supplements such as creatine or branched‑chain amino acids, though evidence is limited. Regular, moderate exercise under supervision can strengthen muscles without triggering severe cramps. In severe cases, medications that improve glycogen breakdown (e.g., dichloroacetate) are being studied, but they are not yet standard care. Close monitoring by a metabolic specialist is essential.
PHKA1 mutations are X‑linked recessive. This means that males who inherit a defective copy will express the disease, while females who inherit one defective copy are typically carriers with minimal or no symptoms. Carrier females can pass the mutation to their children: each son has a 50 % chance of being affected, and each daughter has a 50 % chance of being a carrier. Genetic counseling is recommended for families to discuss testing options and reproductive choices.
Early signs often include unexplained muscle weakness, especially in the legs, frequent muscle cramps during or after mild exercise, and a tendency for muscle pain that does not improve with rest. Parents may also notice that the child has slower growth in muscle mass or struggles with activities that require sustained muscle effort. Early evaluation by a pediatric neurologist or metabolic specialist can help identify these subtle symptoms before they progress.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ